452 related articles for article (PubMed ID: 18512713)
1. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
2. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.
Wolfe F; Michaud K
Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349
[TBL] [Abstract][Full Text] [Related]
3. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
Wolfe F; Michaud K
Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.
Chakravarty EF; Michaud K; Wolfe F
J Rheumatol; 2005 Nov; 32(11):2130-5. PubMed ID: 16265690
[TBL] [Abstract][Full Text] [Related]
6. Cancer in rheumatoid arthritis: occurrence, mortality, and associated factors in a South European population.
Abásolo L; Júdez E; Descalzo MA; González-Alvaro I; Jover JA; Carmona L;
Semin Arthritis Rheum; 2008 Jun; 37(6):388-97. PubMed ID: 17977580
[TBL] [Abstract][Full Text] [Related]
7. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
[TBL] [Abstract][Full Text] [Related]
8. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada.
Brassard P; Lowe AM; Bernatsky S; Kezouh A; Suissa S
Arthritis Rheum; 2009 Mar; 61(3):300-4. PubMed ID: 19248128
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
Ann Rheum Dis; 2005 Oct; 64(10):1414-20. PubMed ID: 15843454
[TBL] [Abstract][Full Text] [Related]
12. Multiple malignant melanomas in a patient with RA treated with methotrexate.
Potter T; Hardwick N; Mulherin D
J Rheumatol; 1998 Nov; 25(11):2282-3. PubMed ID: 9818680
[No Abstract] [Full Text] [Related]
13. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis.
Krause D; Schleusser B; Herborn G; Rau R
Arthritis Rheum; 2000 Jan; 43(1):14-21. PubMed ID: 10643695
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry.
Pallavicini FB; Caporali R; Sarzi-Puttini P; Atzeni F; Bazzani C; Gorla R; Marchesoni A; Favalli EG; Montecucco C
Autoimmun Rev; 2010 Jan; 9(3):175-80. PubMed ID: 19647103
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
16. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignant neoplasms after liver transplantation: a population-based study.
Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
[TBL] [Abstract][Full Text] [Related]
18. Two cases of methotrexate induced lymphomas in rheumatoid arthritis: an association with increased serum IgE.
Kono H; Inokuma S; Matsuzaki Y; Nakayama H; Yamazaki J; Hishima T; Maeda Y
J Rheumatol; 1999 Oct; 26(10):2249-53. PubMed ID: 10529149
[TBL] [Abstract][Full Text] [Related]
19. Mortality in rheumatoid arthritis patients treated with or without methotrexate.
Singer RB
J Insur Med; 2003; 35(3-4):144-9. PubMed ID: 14971085
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
